跳至主要内容
临床试验/NCT07462351
NCT07462351招募中不适用

System-integrated Point-of-Care Ultrasound in Breast Cancer Screening

Region Skane2 个研究点 分布在 1 个国家目标入组 4,800 人开始时间: 2026年3月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Region Skane
入组人数
4,800
试验地点
2
主要终点
Sensitivity

研究概览

简要总结

To assess the feasibility, safety, and clinical performance of community-based breast cancer screening incorporating clinical breast exam and short-termed trained examiners performing AI-supported breast POCUS for triage in limited-resource settings.

详细描述

Following awareness campaign, asymptomatic and symptomatic women are invited to breast cancer screening. The screening intervention consists initially of clinical breast exam (CBE). Those that are positive at CBE or that present with symptoms are further examined with targeted artificial intelligence (AI)-supported breast point-of-care ultrasound (POCUS) on the complaint site. The AI-supported POCUS is performed by clinical nurses or clinical officers that have undergone a short training program and certification process in POCUS examination. In the first stage of the study, the same women will also be examined by an expert on site (breast radiologist). If clinical safety can be determined, the second stage of the study will start in which expert radiologist will not be on site. Ultrasound images will be assessed by breast radiologists that will serve as reference standard (on site in stage 1 and remotely in stage 2). Women positive at POCUS triage (positive ultrasound finding or with predefined alarming clinical symptoms) will be referred to further follow up.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

盲法说明

The result of AI-supported POCUS performed by nurse/clinical officer will be masked for the expert radiologist in the first stage of the study

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Asymptomatic women from the age of 30 with no upper age limit
  • Symptomatic women 18 years or older.

排除标准

  • Individuals unable to comprehend the study information due to language barriers or cognitive impairments.

研究组 & 干预措施

CBE follow by targeted AI-supported POCUS

Experimental

In the first stage, an expert breast radiologist will be involved on site and in the second stage, remotely.

干预措施: AI (Diagnostic Test)

结局指标

主要结局

Sensitivity

时间窗: Estimated 2 months (from enrollment until sufficient number of positive participants according to expert assessment)

The primary endpoint is sensitivity, defined as the proportion of diseased women correctly classified as positive by non-experts using AI-supported POCUS. Expert breast radiologists will be used as reference standard

次要结局

  • Specificity(2 months)
  • Positive Predictive Value(2 months)
  • Negative Predictive Value(2 months)
  • Cancer Detection Rate(2 months)
  • Recall Rate(2 months)
  • False Positive Rate(2 months)
  • Optimal threshold analysis(2 months)
  • Cancer characterstics(6 months)
  • Breast cancer in stage I-II(12 months)
  • WHO Global Breast Cancer Initiative key performance indicators(12 months)
  • Receiver Operating Characteristic and Area Under the Curve(2 months)
  • Usability and Acceptability(2 months)

研究者

发起方
Region Skane
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kristina Lång

MD PhD

Lund University

研究点 (2)

Loading locations...

相似试验